Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

253 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase III trial of protracted compared with split-course chemoradiation for esophageal carcinoma: Federation Francophone de Cancerologie Digestive 9102.
Crehange G, Maingon P, Peignaux K, N'guyen TD, Mirabel X, Marchal C, Verrelle P, Roullet B, Bonnetain F, Bedenne L; Federation Francophone de Cancerologie Digestive 9102. Crehange G, et al. Among authors: bonnetain f. J Clin Oncol. 2007 Nov 1;25(31):4895-901. doi: 10.1200/JCO.2007.12.3471. J Clin Oncol. 2007. PMID: 17971585 Clinical Trial.
Tumor volume and metabolism of prostate cancer determined by proton magnetic resonance spectroscopic imaging at 3T without endorectal coil reveal potential clinical implications in the context of radiation oncology.
Créhange G, Parfait S, Liegard M, Maingon P, Ben Salem D, Cochet A, Funes de la Vega M, Cormier L, Bonnetain F, Mirjolet C, Brunotte F, Walker PM. Créhange G, et al. Among authors: bonnetain f. Int J Radiat Oncol Biol Phys. 2011 Jul 15;80(4):1087-94. doi: 10.1016/j.ijrobp.2010.03.007. Epub 2010 Jul 7. Int J Radiat Oncol Biol Phys. 2011. PMID: 20615624
Early choline levels from 3-tesla MR spectroscopy after exclusive radiation therapy in patients with clinically localized prostate cancer are predictive of plasmatic levels of PSA at 1 year.
Crehange G, Maingon P, Gauthier M, Parfait S, Cochet A, Mirjolet C, Bonnetain F, Cormier L, Brunotte F, Walker P. Crehange G, et al. Among authors: bonnetain f. Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):e407-13. doi: 10.1016/j.ijrobp.2011.03.008. Epub 2011 May 24. Int J Radiat Oncol Biol Phys. 2011. PMID: 21605949
Clinical impact of margin reduction on late toxicity and short-term biochemical control for patients treated with daily on-line image guided IMRT for prostate cancer.
Crehange G, Mirjolet C, Gauthier M, Martin E, Truc G, Peignaux-Casasnovas K, Azelie C, Bonnetain F, Naudy S, Maingon P. Crehange G, et al. Among authors: bonnetain f. Radiother Oncol. 2012 May;103(2):244-6. doi: 10.1016/j.radonc.2011.10.025. Epub 2011 Nov 25. Radiother Oncol. 2012. PMID: 22119374
Hybrid Minimally Invasive Esophagectomy for Esophageal Cancer.
Mariette C, Markar SR, Dabakuyo-Yonli TS, Meunier B, Pezet D, Collet D, D'Journo XB, Brigand C, Perniceni T, Carrère N, Mabrut JY, Msika S, Peschaud F, Prudhomme M, Bonnetain F, Piessen G; Fédération de Recherche en Chirurgie (FRENCH) and French Eso-Gastric Tumors (FREGAT) Working Group. Mariette C, et al. Among authors: bonnetain f. N Engl J Med. 2019 Jan 10;380(2):152-162. doi: 10.1056/NEJMoa1805101. N Engl J Med. 2019. PMID: 30625052 Clinical Trial.
Health-related Quality of Life Following Hybrid Minimally Invasive Versus Open Esophagectomy for Patients With Esophageal Cancer, Analysis of a Multicenter, Open-label, Randomized Phase III Controlled Trial: The MIRO Trial.
Mariette C, Markar S, Dabakuyo-Yonli TS, Meunier B, Pezet D, Collet D, D'Journo XB, Brigand C, Perniceni T, Carrere N, Mabrut JY, Msika S, Peschaud F, Prudhomme M, Bonnetain F, Piessen G; FRENCH, FREGAT. Mariette C, et al. Among authors: bonnetain f. Ann Surg. 2020 Jun;271(6):1023-1029. doi: 10.1097/SLA.0000000000003559. Ann Surg. 2020. PMID: 31404005 Clinical Trial.
253 results